Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (11): 1315-1320.
DOI: 10.19803/j.1672-8629.20240255
LI Yaolei1,2, JIN Hongyu1,2,*, WEI Feng1,2, MA Shuangcheng2,3#
Received:
2024-04-24
Online:
2024-11-15
Published:
2024-11-20
CLC Number:
LI Yaolei, JIN Hongyu, WEI Feng, MA Shuangcheng. Introduction and Quality Factors of Peucedanum Praeruptorum Dunn[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1315-1320.
[1] YE L, FAN S, ZHAO P, et al.Potential Herb-Drug Interactions Between Anti-COVID-19 Drugs and Traditional Chinese Medicine[J]. Acta Pharmaceutica Sinica B, 2023, 13(9): 3598-3637. [2] WANG Q, SUN Q, HUANG Q, et al.The Traditional Uses, Pharmacology, and Phytochemistry of Peucedanum Praeruptorum Dunn[J]. Front Pharmacol, 2024, 15(10): 1352657. [3] LIANG T, HONG J, SHANG Z.The Record of Famous Doctors(名医别录)[M]. Beijing: People’s Health Publishing House, 1986: 122. [4] SONG Z, LI B, TIAN K, et al.Research Progress on Chemical Constituents and Pharmacological Activities of Peucedani Radix and Peucedani Decursivi Radix[J]. Chinese Herbal Medicine(中草药), 2022, 53(3): 948-964. [5] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 1963: 178. [6] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2005: 187. [7] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2010: 248, 317-318. [8] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020: 277, 352. [9] ZHAI X, WANG K, GAO X, et al.Research Progress on Chemical Constituents and Pharmacological Activities of Menispermi Rhizoma[J]. Molecules, 2023, 28(6): 2701. [10] LSHI H, OKADA Y, BABA M, et al.Sudies of Coumarins From The Chinese Drug Qianhu, XXv/l: Structure of A New Simple Coumarin Aivcoside From Bai-Hua Qianhu, Peucedanum Praeruptorum[J]. Chem Pharm Bull, 2008, 56(9): 1349-1351. [11] LIU RM, SUN QH, SHI YR, et al.Isolation and Purification of Coumarin Compounds from the Root of Peucedanum Decursivum (Miq.) Maxim by High-Speed Counter-Current Chromatography[J]. Journal of Chromatography A, 2005, 1076(112): 127-132. [12] XU G, TAN Q, YANG D, et al.Effect of Index Components in Peucedanum Praerupterum by Different Extraction Methods[J]. Asia-Pacific Traditional Medicine(亚太传统医药), 2022, 18(3): 42-44. [13] XU J, KONG L.Studies on the Chemical Composition of the Stem and Leaf of Pseudostellaria Pinnatifida[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2001, 26(3): 178-180. [14] KONG LY, LI M, PEI YH, et al.Studies on the Chemical Composition of Radix et Rhizoma Pinelliae (V)[J]. Chinese Herbal Medicine(中草药), 1993, 24(8): 401-404. [15] CHEN Z, HUANG B, YU Q, et al.Studies on the Chemical Constituents of the Traditional Chinese Medicine, Radix et Rhizoma Pinelliae: the Structures of Four New Coumarins[J]. Acta Pharmaceutica Sinica(药学学报), 1979, 14(8): 486-496. [16] ZHANG C, XIAO Y, LI L, et al.A Study on Chemical Components of Peucedanum Praeruptorum Dunn (V)[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2012, 37(23): 3573-3576. [17] YU N, LIU S, LIANG Y, et al.A Comparsion of Chemical Components of Volatile Oils from the Decocting Pieces of Peucedanum Praeruptorum in Different Regions[J]. Journal of Anhui University of Chinese Medicine(安徽中医学院学报), 2007, 26(1): 44-45. [18] LEI H, ZOU S, ZHANG H, et al.Compositional Analysis of the Volatile Oils of Three Species of Piper Betulae[J]. Journal of Chinese Medicinal Materials(中药材), 2016, 39(4): 795-798. [19] ZHEN Q, SHANG Z.Theory of Pharmacognosy-Classification of Pharmacognosy Tendencies(药性论)[M]. Anhui Science and Technology Press, 2006. [20] LAN M. Yunnan Materia Medica(滇南本草)[M]. Kunming: Yunnan Science and Technology Press, 2008. [21] LI SZ.Compendium of Materia Medica(本草纲目)[M]. Nanchang: Twenty-first Century Press, 2014. [22] LIU Y, DING Y, LI L.Explaination of the Jiangqihuatan Efficacy of Peucedanum Praeruptorum Dunn Based on Network Pharmacology[J]. Guangdong Chemical Industry(广东化工), 2023, 50(6): 174-177, 146. [23] LI G, ZHANG L, ZOU J, et al.Protective effects of Peucedanum Praeruptorum Dunn on Acute Myocardial Ischemia in Mice and Rats[C]. Editorial Department of Chinese Pharmacological Bulletin(中国药理学会第十次全国学术会议专刊), 2009. [24] TU X, WANG J, TU Q, et al.Effects of Peucedanum Praeruptorum Dunn Extract on Left Ventricular Remodeling and Bcl-2, Bax Protein Expression in Aorta Coarctation Rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics(中国临床药理学与治疗学), 2004, 9(4): 394-398. [25] PARK J, KIM J, SHIN J, et al.Anti-inflammatory Effects of Peucedanum Japonicum Thunberg Leaves Extract in Lipopolysaccharide-stimulated RAW264.7 cells[J]. Journal of Ethnopharmacology, 2023, 309(10): 116362. [26] PARK H, JEONG J, PARK S.The Root Extract of Peucedanum Praeruptorum Dunn Exerts Anticancer Effects in Human Non-small-Cell Lung Cancer cells with Different EGFR Mutation Statuses by Suppressing MET Activity[J]. Molecules, 2022, 27(7): 2360. [27] LIAO G, DUAN J, LIN J.The Effect of Peucedunum Extracts on Monoamine Transmitter in Brain Tissues in Rats with Depression[J]. Strait Pharmaceutical Journal(海峡药学), 2016, 28(7): 17-20. [28] XIONG YY, WU FH, WANG JS, et al.Attenuation of Airway Hyperreactivity and T Helper Cell Type 2 Responses by Coumarins from Peucedanum Praeruptorum Dunn in A Murine Model of Allergic Airway Inflammation[J]. Journal of Ethnopharmacology, 2012, 141(1): 314-321. [29] YU CL, YU YL, YANG SF, et al.Praeruptorin A Reduces Metastasis of Human Hepatocellular Carcinoma Cells by Targeting ERK/MMP1 Signaling Pathway[J]. Environmental Toxicology, 2021, 36(4): 540-549. [30] WU MH, LIN CL, CHIOU HL, et al.Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling[J]. International Journal of Molecular Sciences, 2017, 19(1): 10. [31] CHEN Q, LIU X, PAN L, et al.Study on the Effects of Praeruptorin A Combined with Low Concentration of Taxol on Taxol-resistant Ovarian Cancer Cell Line A2780/TAX[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2022, 42(17): 1755-1759, 1765. [32] LI Z, ZHANG F, WANG S, et al.Endothelium-Dependent Vasorelaxant Effects of Praeruptorin a In Isolated Rat Thoracic Aorta[J]. Bioengineered, 2022, 13(4): 10038-10046. [33] XU Z, WANG X, DAI Y, et al.(+/-)-Praeruptorin A Enantiomers Exert Distinct Relaxant Effects on Isolated Rat Aorta Rings Dependent on Endothelium and Nitric Oxide Synthesis[J]. Chemico-Biological Interactions, 2010, 186(2): 239-246. [34] QIU QH.Protective Effect of White-Flowered Prenylidenol Against Cerebral Ischaemia-Reperfusion in Rats by Regulating the Expression of Bcl-2/Bax, Caspase9 and Caspase3[D]. Fuzhou: Fujian Medical University(福建医科大学), 2017. [35] GUAN F, JIN W, ZHANG X, et al.The Effects of Praeruptorin a on the Contraction of Isolated Tracheal Smooth Muscle Previously Induced by High k and Acetylcholine[J]. Journal of China Medical University(中国医科大学学报), 1994, 23(6): 549-552. [36] HU J, LIU R, YANG Z, et al.Praeruptorin A Inhibits the Activation of NF-κB Pathway and the Expressions of Inflammatory Factors in Poly (I:C)-induced RAW264.7 Cells[J]. Chemical Biology & Drug Design, 2023, 102(5): 1110-1120. [37] YU PJ, CI W, WANG GF, et al.Praeruptorin A Inhibits Lipopolysaccharide-Induced Inflammatory Response in Murine Macrophages Through Inhibition of NF-κB Pathway Activation[J]. Phytotherapy Research: PTR, 2011, 25(4): 550-556. [38] YEON JT, CHOI SW, RYU BJ, et al.Praeruptorin A Inhibits In Vitro Migration of Preosteoclasts and In Vivo Bone Erosion, Possibly Due to Its Potential to Target Calmodulin[J]. Journal of Natural Products, 2015, 78(4): 776-782. [39] XU K, CHEN Z, HOU J, et al.Praeruptorin B Inhibits Osteoclastogenesis by Targeting GSTP1 and Impacting on the S-glutathionylation of IKKβ[J]. Biomedicine & Pharmacotherapy, 2022, 154(26): 113529. [40] ZHENG ZG, LU C, THU PM, et al.Correction: Praeruptorin B Improves Diet-Induced Hyperlipidemia and Alleviates Insulin Resistance Via Regulating SREBP Signaling Pathway[J]. RSC Advances, 2019, 9(11): 6101. [41] LIN CL, HUNG TW, YING TH, et al.Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells Through Targeting CTSC and CTSV Expression[J]. International Journal of Molecular Sciences, 2022, 21(8): 2919. [42] OZAKI H, NISHIDONO Y, FUJII A, et al.Identification of Anti-Inflammatory Compounds from Peucedanum Praeruptorum Roots by Using Nitric Oxide-Producing Rat Hepatocytes Stimulated by Interleukin 1β[J]. Molecules, 2023, 28(13): 5076. [43] XUE NM, CHAI MY, YANG WS, et al.Inhibitory Effect of Praeruptorin B on SK-OV-3 Cell Proliferation in Ovari-an Cancer by SREBP-1 c/FASN Signaling Pathway[J]. Chinese Journal of Gerontology(中国老年学杂志), 2021, 41(13): 2773-2777. [44] Editorial Committee of Flora of China, Chinese Academy of Sciences. Flora of China(中国植物志)[M]. Beijing: Science Press, 2004. [45] Chinese Society of Traditional Chinese Medicine (CSTCM). Taoist Medicinal Herbs - Part 88: Xinqianhu (T/CACM 1020.88-2019)[S]. 2019. [46] LIU J, WANG S, LI X, et al.Investigation and Analysis on the Present Situation of Peucedanum Praeruptorum Resources in its Producing area[J]. Modern Agricultural Science and Technology(现代农业科技), 2021, 1(1): 89-92, 99. [47] XIONG YX, CHEN KL, LIU YM, et al.Survey on the resources of the Medicinal Plant Pseudourostyla Cristata[J]. Lishizhen Medicine and Materia Medica(时珍国医国药), 2013, 24(11): 2786-2789. [48] SHI T, ZHANG X, ZHANG K, et al.Study of Extracting Peucedanum Praeruptorum Planted Area in Ningguo of Anhui Province Based on multi-source and multi-phase image[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2017, 42(22): 4362-4367. [49] Group Standard.Commodity Specification Grade of Chinese Herbal Medicines-Qianhu (T/CACM 1021.74-2018)[S]. Beijing, Chinese Society of Traditional Chinese Medicine, 2018. [50] LIU TL, JIANG V, SHU GP, et al.Visual Analysis of Research Hotspots and Trends and Research on Origin and Market of Peucedani Radix[J].Chinese Herbal Medicine(中草药), 2022, 53(24): 7855-7863. [51] LUO M, XU G, TAN QS, et al.Response of Medicinal Quality to Altitude Gradient in Peucedanum Praeruptorum Dunn[J]. Chinese Wild Plant Resources(中国野生植物资源), 2022, 41(11): 20-24. [52] YANG L, KANG X, DU W, et al.Effect of Altitude of Producing Area on Contents of Praeruptorin A and Praeruptorin B in Qianhu(Peucedani Radix)[J]. Chinese Archives of Traditional Chinese(中华中医药学刊), 2021, 39(8): 14-18. [53] LIANG W, HU Y, PU J, et al.Correlation Analysis Between Active Ingredients Contents and Soil Factors in Peucedani Radix[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2021, 38(11): 1302-1308. [54] XU P, ZHANG G, YU Y, et al.Effects of Cultivation Methods on Growth and Quality of Peucedani Radix[J]. Modern Chinese Medicine(中国现代中药), 2023, 25(3): 559-567. [55] SONG C, LI X, JIA B, et al.Comparative Transcriptomics Unveil the Crucial Genes Involved in Coumarin Biosynthesis in Peucedanum Praeruptorum Dunn[J]. Frontiers in Plant Science, 2022, 13(17): 899819. [56] WANG ZW, ZHANG YF, LU J, et al.Study on the Main Biological Characteristics and Growth and Development Pattern of the White-Flowered Radix et Rhizoma Pinelliae L.[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2007, 32(2): 145-146. [57] SHI X, HUANG Q, GUO Z, et al.Study on the Key Factors Affecting the Quality of Peucedani Radix[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2022, 39(2): 192-195. [58] XIE J, TANG X, XIE C, et al.Comparative Analysis of Root Anatomical Structure, Chemical Components and Differentially Expressed Genes Between Early Bolting and Unbolting in Peucedanum Praeruptorum Dunn[J]. Genomics, 2023, 115(2): 110557. [59] CHU S, CHEN L, XIE H, et al.Comparative Analysis and Chemical Profiling of Different forms of Peucedani Radix[J]. Journal of Pharmaceutical and Biomedical Analysis, 2022, 189(11): 113410. [60] LI SY.Study on the Quality Evaluation Method of Radix et Rhizoma Pinelliae and the Concoction Process of Radix et Rhizoma Pinelliae[D]. Nanjing: Nanjing University of Traditional Chinese Medicine(南京中医药大学), 2022. [61] HU C, PAN J, XU Y, et al.Residual Levels and Health Risks of Organochlorine Pesticides and Heavy Metals in the New Eight Genuine Medicinal Materials in Zhejiang(New Zhebawei)[J]. Environmental Science & Technology(环境科学与技术), 2023, 46(1): 203-209. [62] ZHOU Q, DONG J, JIANG Y, et al.Determination of Banned Pesticide Residues in Foregut by SPE-LC-MS/MS and SPE-GC-MS/MS and Analysis of Results[J]. Zhejiang Journal of Traditional Chinese Medicine(浙江中医杂志), 2022, 57(12): 924-927. [63] HUANG P.Study on the Improvement of Quality Standard of Sprain Return Capsule[D]. Nanjing: Nanjing University of Chinese Medicine(南京中医药大学), 2023. [64] LI Y, WANG Z, LI H, et al.Heavy Metal Residual and Related Elemental Species in Polygonum Cillinerve (Nakai) Ohwl[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(11): 1234-1237. |
[1] | LU De, XU Wenyan, LIU Jinxin, PEI Yusheng. Discussion and analysis of bacterial endotoxin problems in FDA warning letters [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 857-862. |
[2] | ZHANG Xiaoming, LYU Ping, HU Xinyue, DING Xiaoli, LI Jing, LIANG Chenggang. Detection of single-chain precursor residues in insulin glargine by ELISA [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 290-294. |
[3] | WANG Dandan, WANG Ying, YAO Lingwen, LIU Yuanxi, JIN Hongyu, MA Shuangcheng. Determination of residual solvents in extract of Coleus amboinicus by headspace-gas chromatography [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 295-299. |
[4] | WANG Changshun, WANG Xiaolei, DUAN Jiping, YUAN Hao, LIU Yongli, ZHAO Ding. Effect of sulfur fumigation on quality of Angelica dahurica and alternative processing methods in producing areas [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 355-360. |
[5] | LEI Jingqi, ZHANG Zezhao, REN Dong, WANG Xinguo, NIU Liying. Determination of 15 Chemical Constituents in Dandelion Leaves from Different Areas of Production Based on UPLC-MS/MS [J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1256-1263. |
[6] | LI Yiwen, CAO Keming, LAN Yuze, SU Shuang, MA Hongliang, ZHANG Lili, CHANG Xiaohong, LI Bo. Rational Use of Traditional Chinese Medicine Decoction Pieces in Outpatient Clinic of a Hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1293-1298. |
[7] | FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe. Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24. |
[8] | WANG Zhao, ZHAO Jianfeng, YU Xinlan, JIN Hongyu, MA Shuangcheng. Radiation screening of Chaihu Shugan pills via photostimulated luminescence [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 514-518. |
[9] | LI Ning, JIANG Xiaoya, ZHANG Zezhao, GAO Le, WANG Xinguo, LIU Xiaoming. Preparation and quality evaluation of standard decoctions of Rosa chinensis Jacq. [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 397-402. |
[10] | CAI Yuluo, GUO Jiahui, Wang Xinguo, TIAN Yilong, WANG Meng, NIU Liying, LI Junshan. Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 348-352. |
[11] | WANG Guoying, ZHOU Gang, WANG Qin, JI Ziwei, NING Xiao, CUI Li. Analysis of impurity spectra and quality control of betahistine hydrochloride injection based on HPLC-QE-MS technology [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1332-1338. |
[12] | HAO Gang, HAN Feng, ZHOU Gang, WU Xing, YAN Hao, LI Xuyang, HOU Hailing, NING Xiao, CUI Li. Methodological study of adenosylcobalamin bacterial endotoxin examination for injection [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1351-1356. |
[13] | WANG Zhao, LIU Yue, ZAN Ke, LI Hailiang, JIN Hongyu, MA Shuangcheng. Preliminary study on extraction technology of tea extract used for Xinnaojian preparation [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1362-1367. |
[14] | TAN Liyuan, CAI Tong, WANG Yan. Research progress in quantitative analysis methods for chemical reference substances [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1209-1216. |
[15] | LIU Bo, GUO Yunxiao, LIU Lisha, FAN Huihong. Research progress in key technologies for quality control of snake venom hemocoagulase drugs [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1195-1200. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||